Condition
Acute Coronary Syndrome (ACS) clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Acute Coronary Syndrome (ACS) clinical trials that are recruiting, at sites in 5 countries (most in China (2), Estonia (1), Spain (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 5Countries
Newest Acute Coronary Syndrome (ACS) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Telehealth-enhanced hybrid cardiac rehabilitation versus clinic-based rehab after an acute coronary syndrome | — | New York, New York | Recruiting | Apr 21, 2026 |
| Transcutaneous auricular vagus nerve stimulation for depression after heart procedures | — | Xi'an, Shaanxi | Recruiting | Mar 6, 2026 |
| AI reading of ECGs to find occlusion myocardial infarction | — | Lugano, Canton Ticino | Recruiting | Jul 22, 2025 |
| Drug-coated balloon with bail-out bioresorbable scaffold versus scaffold alone for new coronary artery blockages | — | Tallinn | Recruiting | Jun 26, 2025 |
| Comparing orbital atherectomy and intravascular lithotripsy for calcified coronary nodules | — | Alicante, Alicante and 5 other locations | Recruiting | Dec 17, 2024 |
| Using drug-coated balloons to treat vulnerable atherosclerotic plaques in heart patients | — | Beijin, Beijing Municipality and 17 other locations | Recruiting | Apr 15, 2024 |
All recruiting trials (6)
-
Telehealth-enhanced hybrid cardiac rehabilitation versus clinic-based rehab after an acute coronary syndrome
This trial tests whether TeleheartCR, a hybrid program combining telehealth, home, and clinic sessions, helps people who had an acute coronary syndrome complete cardiac rehab and improve their fitness as well as traditional clinic-based rehab.
-
Transcutaneous auricular vagus nerve stimulation for depression after heart procedures
This study tests whether at-home taVNS can help reduce depressive symptoms in adults 18–80 who recently had PCI for ACS.
-
AI reading of ECGs to find occlusion myocardial infarction
This trial tests whether an AI tool that reads ECGs can help doctors identify and treat occlusion myocardial infarction faster in adults with suspected acute coronary syndrome who don't meet STEMI criteria.
-
Drug-coated balloon with bail-out bioresorbable scaffold versus scaffold alone for new coronary artery blockages
This test sees if using a drug-coated balloon with bail-out bioresorbable scaffold works as well as using a bioresorbable scaffold alone for adults 18–68 getting PCI for new coronary artery blockages, including certain heart attacks and unstable angina.
-
Comparing orbital atherectomy and intravascular lithotripsy for calcified coronary nodules
This pilot trial will see if orbital atherectomy or intravascular lithotripsy better prepares OCT-identified calcified coronary nodules for stent placement in adults with coronary artery disease.
-
Using drug-coated balloons to treat vulnerable atherosclerotic plaques in heart patients
This study is testing if a special balloon treatment can help heart patients with risky plaque in their arteries feel better compared to standard medication.
Related topics
Quick answers
How many Acute Coronary Syndrome (ACS) clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in China (2 trials), Estonia (1 trial), Spain (1 trial), United States (1 trial), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.